In Russia, the first vaccinations with Sputnik V began last August. Due to its comparatively short development and testing period, there were numerous reservations about the vaccine in the rest of Europe. Thomas Mertens, the chairman of the permanent vaccination commission (Stiko), did away with these prejudices in an interview with the “Rheinische Post”. “It’s a good vaccine that will probably be approved in the EU at some point. The Russian researchers are very experienced with vaccinations. Sputnik V is cleverly built, ”the doctor and virologist told the daily newspaper.
Approval is still pending in Europe
While the vaccine is already gaining popularity from medicine and research, its approval is still being examined by the European Medicines Agency (EMA). The situation is similar with the vaccine from the American company Johnson & Johnson, which is to be approved soon. The great advantage of it is that it unfolds its full effectiveness after just one injection. The preparations of the manufacturers Pfizer / Biontech, Astrazeneca and Moderna are already inoculated in this country.